Jin Medical International (ZJYL) Current Deferred Revenue (2022 - 2025)
Historic Current Deferred Revenue for Jin Medical International (ZJYL) over the last 4 years, with Q1 2025 value amounting to -$303500.0.
- Jin Medical International's Current Deferred Revenue fell 15548.57% to -$303500.0 in Q1 2025 from the same period last year, while for Mar 2025 it was -$303500.0, marking a year-over-year decrease of 15548.57%. This contributed to the annual value of $671414.0 for FY2024, which is 544.78% down from last year.
- Per Jin Medical International's latest filing, its Current Deferred Revenue stood at -$303500.0 for Q1 2025, which was down 15548.57% from $671414.0 recorded in Q3 2024.
- In the past 5 years, Jin Medical International's Current Deferred Revenue ranged from a high of $830305.0 in Q3 2022 and a low of -$303500.0 during Q1 2025
- Moreover, its 4-year median value for Current Deferred Revenue was $609201.0 (2024), whereas its average is $360223.0.
- In the last 5 years, Jin Medical International's Current Deferred Revenue surged by 28607.06% in 2024 and then crashed by 15548.57% in 2025.
- Over the past 4 years, Jin Medical International's Current Deferred Revenue (Quarter) stood at $830305.0 in 2022, then decreased by 14.48% to $710099.0 in 2023, then dropped by 5.45% to $671414.0 in 2024, then crashed by 145.2% to -$303500.0 in 2025.
- Its Current Deferred Revenue was -$303500.0 in Q1 2025, compared to $671414.0 in Q3 2024 and $546988.0 in Q1 2024.